Interferon alfa-2b

Interferon alfa-2b is an antiviral drug discovered and marketed by Schering-Plough under the tradename Intron-A®. It has been used for a wide range of indications, including viral infections and cancers.

This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, chronic myelogenous leukemia, multiple myeloma, follicular lymphoma, carcinoid tumor, and malignant melanoma.